Operating a women's health care center, we clearly understand the urgency for making substantive advances in the detection and management of breast disease. Diagnostic imaging plays an imperative and vital role in the fight against breast cancer.

The utilization of the Aurora System provides an effective and timely coordination of all imaging modalities, especially when critical correlations are being made by breast imaging specialists. What's more, the Aurora System is available exclusively for breast imaging, there is no competition for its use for other types of imaging studies - enabling women with suspected breast disease to have immediate and on-time access to a Breast MRI exam.

As a diagnostic imaging tool, the Aurora Dedicated Breast MRI System is ideal for a wide range of indications in breast disease management including:

Characterize Lesions: Aurora Breast MR imaging may be indicated to identify and characterize malignant vs. benign lesions in women with equivocal mammography and/or ultrasound findings and thereby reduce the number of biopsies resulting from false positive mammograms and/or ultrasound examinations. These attributes are especially important in women with impaired mammography due to dense breast tissue.

Detect Occult Cancer: Aurora Breast MR imaging may be indicated to detect occult primary breast cancer in women presenting with metastatic disease and no known primary tumor. Aurora Breast MR imaging may also be indicated to detect occult disease in the contralateral breast or multifocal/multicentric disease in the ipsilateral breast.

Determine the Extent of Cancer: Aurora Breast MR imaging may be indicated to evaluate the extent of disease prior to treatment; determine the feasibility of breast conservation vs. mastectomy and the potential need for radiation, chemotherapy, or chest wall resection. Aurora Breast MR imaging may be particularly useful to determine the extent of disease in women with lobular carcinoma histology.

Monitor Cancer Therapy: Aurora Breast MR imaging may be indicated to distinguish post-operative and/or post-radiation therapy scarring from recurrent cancer. Aurora Breast MR imaging may also be indicated to evaluate chemotherapeutic effectiveness and the extent of residual disease in patients undergoing neoadjuvant or induction chemotherapy and to monitor the effectiveness of chemopreventive therapy such as Tamoxifen.

Evaluate Patients with Positive Surgical Margins for Residual Cancer: Aurora Breast MR imaging performed soon after surgery may be indicated to determine the presence of significant residual disease in patients with positive surgical margins and thus aid in the determination of further surgery, either re-excision of margins or mastectomy.

Exclude the Existence of Cancer in High-Risk Women: Aurora Breast MR imaging may exclude the existence of or identify cancer in women at increased risk for breast cancer based upon family history, genetic markers or high-risk histology.

Evaluate Implant Integrity and Detect Cancer in Women with Breast Augmentation: Aurora Breast MR imaging is the most reliable method for imaging breasts to determine implant rupture or leakage. As opposed to mammography and ultrasound, breast MR imaging is not impaired by the presence of silicone injections or implant augmentation in the detection of cancer.